CannaPharmaRx Inc
OTC:CPMD
Balance Sheet
Balance Sheet Decomposition
CannaPharmaRx Inc
CannaPharmaRx Inc
Balance Sheet
CannaPharmaRx Inc
| Dec-1998 | Dec-1999 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
1
|
1
|
|
| PP&E Net |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
5
|
6
|
5
|
|
| PP&E Gross |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
5
|
6
|
5
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
7
|
0
|
0
|
5
|
5
|
|
| Other Long-Term Assets |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
10
+323%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
0
-99%
|
0
-83%
|
0
N/A
|
10
N/A
|
16
+59%
|
9
-45%
|
0
-99%
|
5
+4 637%
|
12
+117%
|
11
-8%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
3
|
3
|
7
|
9
|
5
|
|
| Accrued Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
10
|
9
|
9
|
7
|
8
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
1
|
1
|
5
|
|
| Total Current Liabilities |
0
|
2
|
5
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
1
|
4
|
6
|
18
|
13
|
17
|
18
|
26
|
|
| Long-Term Debt |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
6
|
0
|
0
|
6
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
|
| Total Liabilities |
0
N/A
|
2
+738%
|
8
+227%
|
1
-93%
|
1
+17%
|
1
-16%
|
0
N/A
|
0
N/A
|
0
+100%
|
0
+45%
|
2
+621%
|
1
-67%
|
1
+37%
|
1
+1%
|
10
+977%
|
11
+7%
|
18
+57%
|
13
-26%
|
23
+75%
|
24
+5%
|
31
+28%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
3
|
1
|
|
| Retained Earnings |
0
|
5
|
24
|
17
|
18
|
17
|
17
|
17
|
17
|
17
|
21
|
33
|
34
|
34
|
37
|
57
|
77
|
86
|
95
|
91
|
101
|
|
| Additional Paid In Capital |
2
|
12
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|
17
|
21
|
32
|
33
|
33
|
37
|
62
|
68
|
73
|
75
|
76
|
80
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
2
N/A
|
7
+260%
|
8
N/A
|
1
+93%
|
1
-17%
|
1
+16%
|
0
N/A
|
0
N/A
|
0
-100%
|
0
-45%
|
0
N/A
|
1
-134%
|
1
-41%
|
1
-1%
|
0
+70%
|
5
N/A
|
9
N/A
|
13
-47%
|
17
-34%
|
12
+30%
|
20
-63%
|
|
| Total Liabilities & Equity |
2
N/A
|
10
+323%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
0
-99%
|
0
-83%
|
0
N/A
|
10
N/A
|
16
+59%
|
9
-45%
|
0
-99%
|
5
+4 637%
|
12
+117%
|
11
-8%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
3
|
5
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
17
|
18
|
18
|
18
|
19
|
36
|
47
|
125
|
274
|
435
|
656
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
1
|
|